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Abstract
Background: The aims of the present study were to investigate the impact of three whole blood donations on
endurance capacity and hematological parameters and to determine the duration to fully recover initial endurance
capacity and hematological parameters after each donation.
Methods: Twenty-four moderately trained subjects were randomly divided in a donation (n = 16) and a placebo (n = 8)
group. Each of the three donations was interspersed by 3 months, and the recovery of endurance capacity and
hematological parameters was monitored up to 1 month after donation.
Results: Maximal power output, peak oxygen consumption, and hemoglobin mass decreased (p < 0.001) up to 4 weeks
after a single blood donation with a maximal decrease of 4, 10, and 7%, respectively. Hematocrit, hemoglobin
concentration, ferritin, and red blood cell count (RBC), all key hematological parameters for oxygen transport, were
lowered by a single donation (p < 0.001) and cumulatively further affected by the repetition of the donations (p < 0.001).
The maximal decrease after a blood donation was 11% for hematocrit, 10% for hemoglobin concentration, 50% for
ferritin, and 12% for RBC (p < 0.001). Maximal power output cumulatively increased in the placebo group as the maximal
exercise tests were repeated (p < 0.001), which indicates positive training adaptations. This increase in maximal power
output over the whole duration of the study was not observed in the donation group.
Conclusions: Maximal, but not submaximal, endurance capacity was altered after blood donation in moderately trained
people and the expected increase in capacity after multiple maximal exercise tests was not present when repeating
whole blood donations.
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Key Points
 Maximal power output, VO2peak, and hemoglobin
mass were decreased up to 4 weeks after a single
blood donation in moderately trained people
 Beneficial training adaptations seemed somewhat
lowered by repeated whole blood donations
 Key hematological parameters for oxygen transport
were lowered by a single donation and cumulatively
further affected by their repetition
 Measures to counteract the alterations in
hematological parameters should be developed to
minimize the impact on endurance capacity and
thereby to attract more athletes to become donors
 Athletes constitute a very healthy potential donor
population and should consider becoming plasma
donors as there also is an increased need for plasma
worldwide and plasma donation does not affect their
hemoglobin levels at all
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Background
The demand for blood and blood products evolves due
to different factors. On the one hand, blood transfusion
triggers have become stricter reducing the need for the
transfusion of red cells [1]. On the other hand, as a
result of medical progress, more red cells are required
[2, 3] due to more complex surgical procedures, increas-
ing number of transplantations, advances in hematology
and oncology for which transfusions are necessary [3–5],
and aging of the population [6, 7] with increasing rates
of medical interventions with old age [8]. Demand for
plasma and plasma-derived products such as coagulation
factors, albumin, and immunoglobulins increases world-
wide mainly due to new indications and an increased
utilization in countries as they become more developed.
On the donor side, more and more tightened selection
criteria exist [9–11], making finding enough donors a
continuous effort. The World Health Organization
drawn up many strategies and campaigns to encourage
people to become or stay blood donors. Despite the ef-
forts, these initiatives do not always attract the preferred
population [12], which consists of voluntary, unpaid
blood donors who give blood and plasma mainly for al-
truistic reasons [2], and seems to be the healthiest group
because of their lower risk of blood-borne diseases [2].
From this perspective, sport athletes would be an inter-
esting donor population to be recruited. However, due
to the potential detrimental effects on sport perform-
ance, athletes are not easily convinced to give blood on a
regular basis. It is therefore essential to better under-
stand how blood donation impacts sport performance
and, in turn, to inform athletes adequately.
After donating one unit of whole blood, hematological
parameters decrease immediately [13–15]. Blood with-
drawal causes a reduction of plasma volume which is al-
most completely restored 24–48 h after donation [14].
Recovery of hematocrit, ferritin, and hemoglobin con-
centrations takes more time as those parameters have
been found to be reduced beyond 4 weeks after donation
[15], which corresponds approximately to the period
needed for total hemoglobin mass to return to baseline
levels [16]. Of note, serum ferritin concentration de-
creases further when donations are repeated [17]. While
the effect of one blood donation on hematological pa-
rameters is quite well documented, there is a paucity of
data after repeated blood donations while donors are in-
vited to give blood three or four times a year. As already
evidenced for serum ferritin, it can be hypothesized that
changes in hematological parameters are more severe
when donations are repeated regularly, which could lead
to iron deficiency.
As the aforementioned hematological parameters have
a critical role in the regulation of oxygen-carrying cap-
acity and thereby maximal oxygen uptake (VO2max),
blood donation is expected to negatively impact endur-
ance performance [18–20]. In 1995, Panebianco et al.
showed that blood donation reduced maximal perform-
ance in cyclists for at least 1 week, while submaximal
performance was not affected [21]. Other studies con-
firmed that VO2max was reduced after blood donation
from a few hours and days [20–23] until 2 weeks [24].
Blood donation does not only reduce VO2max as time to
exhaustion has been shown to be altered as well [13].
Taken together, those results show that VO2max and,
more broadly, maximal endurance performance is re-
duced after a blood donation. However, the conclusions
of the few studies looking at recovery of performance or
VO2max after donation have to be taken with caution as
no placebo group was included, which preclude from
distinguishing the effects of donation itself and the effect
of repeating strenuous exercise for determining maximal
parameters.
Although several studies analyzed the influence of
whole blood donation on endurance performance, there
is a paucity of data reporting the time necessary to fully
recover. Most of the studies stopped data collection after
a few days. Furthermore, whereas most donors usually
give blood three or four times a year, no study has evalu-
ated the effect of repeated donations on endurance per-
formance. Therefore, the aims of the present study were:
(1) to investigate the impact of three donations on en-
durance capacity and hematological parameters and (2)
to determine the duration to fully recover initial endur-
ance capacity and hematological parameters after each
donation. A placebo group was included to isolate the
effects of blood donation from those of repeated strenu-
ous exercise.
Methods
Subjects
A statistical power analysis was performed to determine
the optimal number of subjects needed to find a differ-
ence in the mean of 15% (expected for VO2max) with a
standard deviation corresponding to 20% of the means
with a power of 80%. Twenty-four young men (n = 8 in
the placebo group and n = 16 in the donation group,
randomly assigned) volunteered to participate in a longi-
tudinal study (Table 1) (Fig. 1). Inclusion criteria were as
follows: recreational sportsmen (1 to 6 h sport a week),
age 18 to 30 years, BMI 20 to 28 kg⋅m2 -1, and no
contraindication to perform exercise at maximal inten-
sity. Subjects were instructed to refrain from vigorous
physical activity 2 days before every experimental session
and from alcohol and smoking 1 day before. During the
whole duration of the study, subjects were asked to
maintain their habitual lifestyle, i.e., physical activity and
diet. Furthermore, all participants came to the laboratory
around the same time to minimize diurnal variations.
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All participants provided written informed consent after
explaining all potential risks of the study and the right
to withdraw at any time. The study was approved by the
Ethics Committee of the KU Leuven and the investiga-
tion was performed according to the principles outlined
in the Declaration of Helsinki.
Four subjects (one in the placebo group and three in
the donation group) gave up before the end of the first
set of experiments. As they were incomplete, their data
were not included in the analyses, resulting in a total
number of subjects of 20 for the first set of experiments.
Two additional subjects in the placebo group gave up
before the end of the second set of experiments, result-
ing in a total of 18 subjects for the second and the third
sets of experiments. Five subjects gave up due to the
high time-consuming character of the study and one
subject got injured independently of the study.
Exercise Testing
One week before the first test series (-1w), subjects re-
ported to the laboratory to perform a maximal incre-
mental test (Fig. 2). Weight and height were measured.
After 10 min in sitting position, three blood samples
were taken in an antecubital vein (one in a 10-ml clot
activator tube, one in a 4.5-ml lithium heparin tube, and
one in a 3-ml EDTA tube). Fifteen minutes after blood
sampling, a peak oxygen consumption (VO2peak) test
was performed on a bicycle ergometer (Avontronic,
Cyclus 2, Leipzig, Germany) in a ventilated laboratory
with a constant temperature of 18 °C. Seat height was
recorded during the first test and remained constant
throughout the 18 tests. Subjects were also blinded for
time, power, and heart rate. The protocol started at
70 W, followed by incremental loads of 30 W every
2 min until exhaustion. The maximal power output
(Pmax) was calculated as the last step completed plus
the last increment corrected for the sustained duration,
which corresponded to the Total Time of the test.
Cadence must be maintained at 85–90 rpm. Oxygen
consumption (VO2), carbonic dioxide production
(VCO2) (Metalyzer II, Cortex, Leipzig, Germany) as well
as heart rate (HR, Polar, Kempele, Finland) were con-
tinuously monitored during the test. Oxygen pulse was
calculated by dividing VO2peak and HRmax at the end
of the test. Blood lactate was measured before, during
(at 190 W), and at the end of the test by taking a capil-
lary blood sample (5 μl) from an earlobe (Lactate Pro,
Arkray, Japan). Subjects were not verbally encouraged
during the entire test. The VO2peak test and blood sam-
pling were repeated 2 days (2d), 1 week (1w), 2 weeks
(2w), and 4 weeks (4w) after each of the three blood dona-
tions (see below) following exactly the same conditions
(Fig. 2). Due to ethical considerations, the VO2peak test
was not performed the day of the donation (0d).
Hemoglobin Mass Measurement
Due to practical issues, hemoglobin mass was deter-
mined on half of the subjects (n = 3 in placebo and n = 7
in donation). Hemoglobin mass was measured 45 min
after the end of the incremental test to ensure that venti-
lation had returned to basal levels using a modified
Table 1 Subject characteristics at the start of the study
Placebo Donation p value
Age (years) 27.2 ± 4.35 25.6 ± 0.76 0.62
Weight (kg) 75.1 ± 4.51 73.8 ± 1.96 0.75
Height (cm) 179.5 ± 1.67 180.2 ± 1.82 0.81
BMI (kg/m2) 23.2 ± 1.06 22.7 ± 0.49 0.64
Sport/week (h) 5.1 ± 0.74 3.9 ± 0.55 0.22
VO2peak (ml/kg
/min) 56.9 ± 4.63 56.7 ± 1.45 0.97
Values are means ± SEM. n = 8 in placebo and n = 16 in donation
Enrolled in the study (n=24) 
Placebo (n=8) Donation (n=16) 
Hb mass 
measurement (n=4) 
No Hb mass 
measurement (n=4) 
Hb mass 
measurement (n=8) 
No Hb mass 
measurement (n=8) 
1 drop-out 2 drop-outs 1 drop-out 
Hb mass 
measurement (n=3) 
No Hb mass 
measurement (n=4) 
Hb mass 
measurement (n=7) 
No Hb mass 
measurement (n=6) 
Beginning of test series 1 
End of test series 1 
2 drop-outs 
Hb mass 
measurement (n=3) 
No Hb mass 
measurement (n=2) 
Hb mass 
measurement (n=7) 
No Hb mass 
measurement (n=6) Test series 2 & 3 
Placebo (n=5) Donation (n=13) 
Fig. 1 Subject flow chart
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version [25] of the optimized carbon monoxide (CO) re-
breathing method developed by Schmidt and Prommer
[26]. This method consists in taking capillary earlobe
blood samples (70 μl) for the determination of carboxy-
hemoglobin concentrations (ABL 90 Flex Radiometer,
Zoetermeer, The Netherlands). Five samples were taken
at basal and averaged and two other samples were taken
6 and 8 min after the initial inhalation of the CO dose.
A CO dose of 1.0 ml⋅kg−1 body mass was administered
and rebreathed for 2 min trough a glass spirometer
(Blood tec, Bayreuth, Germany). Before and 4 min after
the initial inhalation of CO, end-tidal CO concentration
in the lungs was measured (PAC 5500 CO, Dräger,
Wemmel, Belgium). At the end of the test, the
remaining amount of CO located in the system (spirom-
eter + breathing bag) was determined. The hemoglobin
mass was calculated and reported relative to body weight
according to Steiner and Wehrlin [25, 27]. The measure-
ments were repeated at -1w, 0d, 2d, 1w, 2w, and 4w
from each blood donation.
Blood Donation
One week after exercise pre-testing (0d), participants re-
ported to the Red Cross Center in Leuven (Belgium).
They underwent a blood donation of 470 ml according
to the Belgian Law of 01/02/2005 (Donation) or had a
similar sensation of undergoing a blood donation (pla-
cebo) as described in Howell et al [28]. During each do-
nation or simulation of donation, the subjects were
blinded and they were listening to music through a
headset. To study the repetitive effect, blood donation
was repeated after 3 months (second test series) and
after 6 months (third test series).
Blood Analyses
The lithium heparin and the EDTA tubes were analyzed
within 24 h following blood drawing in the laboratory of
the university hospital (Leuven). The following parameters
were analyzed using an automated device (Sysmex XE-
5000TM, Hoeilaart, Belgium): blood platelets, hematocrit,
hemoglobin concentration, mean corpuscular hemoglobin
(MCH), mean corpuscular hemoglobin concentration
(MCHC), mean corpuscular volume (MCV), mean plate-
let volume (MPV), red blood cell count (RBC), red blood
cell distribution width (RDW), white blood cell count
(WBC), ferritin, iron, transferrin, and transferrin satur-
ation. The clot activator tubes were centrifuged at the end
of each experimental day for 6 min at 3000 g at 4 °C. The
supernatant was collected and stored at −80 °C. Serum
erythropoietin was determined using the Human Erythro-
poietin Elisa Kit (Abcam, Cambridge, UK).
Statistical Analysis
All values are expressed as mean ± SEM. A mixed ANOVA
model (SAS Statistical Software) was used with the subjects
as a random variable and groups (placebo and donation)
and condition (time) as fixed independent variables. As a
group effect was only observed for hematocrit, hemoglobin,
ferritin, and RBC, a mixed ANOVA model with the time as
a fixed independent variable was applied to the placebo and
to the donation group separately (Table 2). When appropri-
ate, contrast analyses were performed to compare means.
Statistical significance was set at p < 0.05.
Results
Single Versus Repeated Whole Blood Donations
Differently Alter Endurance Capacity
Pmax decreased by 3% 2d, by 4% 1w, and 2w and by 2%
4w after the first blood donation while remaining constant
in the placebo group (Fig. 3a). In the placebo group, a
training effect was observed starting from the second test
series as pre-values from the second (+3%) and the third
test series (+5%) were higher compared to the pre-values
from the first one. Within the placebo group, Pmax was
higher at 2d, 1w, 2w, and 4w than at -1w in test series 2
and at 2w in test series 3. This training effect was not ob-
served in the donation group as Pmax did not increase
with time. Logically, the results for total time paralleled
the results of Pmax (Table 3). VO2peak decreased by 5%
2d, by 7% 1w, by 10% 2w, and by 7% 4w after the first
blood donation (Fig. 3b). VO2peak also decreased in the
placebo group after 1w (−5%) and 4w (−8%) in test series
1, with no further modification in test series 2 and 3. In
the donation group, pre-values of VO2peak were lower in
test series 2 and 3 compared to pre-values in test series 1.
Within test series 2, VO2peak decreased only 2d after
donation (−4%) and returned to basal values 1w after. In
test series 3, VO2peak decreased by 7% 2d, by 9% 1w, by
11% 2w, and by 7% 4w after blood donation. In summary,
the first blood donation had a higher negative effect on
endurance capacity than the second and the third dona-
tions as both Pmax and VO2peak decreased after the first
blood donation while only VO2peak decreased after the
second and third donations. Our data also indicate that
the positive training effect on Pmax observed in the
Exercise 
Blood 
Donation
Hb mass
-1w 0d 2d 1w 2w 4w 
X3 
Fig. 2 Schematic study design
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placebo group during the second and the third test series
was not present in the donation group.
Whole Blood Donation Does Not Modify Lactate, Heart
Rate, or Ventilation
Submaximal lactate values at 190 W decreased steadily
(Table 2) from the first (3.8 mM in placebo and 2.8 mM
in donation, Table 3) to the 15th exercise test (1.7 mM
in each group) with no difference between the groups,
showing a similar training effect at submaximal intensity
in both groups. A general decrease across time was also
observed for post-exercise lactate values but the de-
crease was more pronounced in the donation group
(from 13.6 to 9.2 mM, p < 0.001) compared to the
placebo group (from 11.9 to 8.7 mM, p = 0.0993)
(Tables 2 and 3). Maximal heart rate recorded at the end
of the exercise test decreased with time in the donation
group and tended to decrease in the placebo group as
well (p = 0.0699, Table 2). Oxygen pulse decreased over
time and within each donation in the donation group
only (Tables 2 and 3). The maximal ventilation showed
some fluctuation over time but no clear training effect
or any effect of donation could be observed (Table 3).
Whole Blood Donation Reduces Hemoglobin Mass and
Increases Serum Erythropoietin
A single blood donation reduced hemoglobin mass by
7% the day of the donation and by 5% until 2 weeks after
(Fig. 4a). Pre-donation values were recovered after
4 weeks. The second and the third donations lead to
similar reductions in hemoglobin mass except that
4 weeks after the third donation hemoglobin mass was
still 4% lower than pre-donation values. No change in
hemoglobin mass (Fig. 4a) or serum erythropoietin con-
centration (Fig. 4b) was observed in the placebo group.
A general increase in serum erythropoietin over time
Table 2 F and p values from the global ANOVA analyses
All subjects Placebo Donation
Group Time Time Time
F value p value F value p value F value p value F value p value
Pmax 0.43 0.5219 9.54 <0.0001 4.13 <0.0001 6.48 <0.0001
VO2peak 0.32 0.5775 4.31 <0.0001 0.81 0.6573 5.46 <0.0001
Hb mass 0.80 0.3959 3.82 <0.0001 0.51 0.9255 6.03 <0.0001
EPO 0.10 0.7631 2.88 0.0003 0.76 0.7181 2.62 0.0019
Lactate 190W 0.18 0.6722 9.10 <0.0001 8.34 0.0008 3.22 <0.0001
Lactate post 0.01 0.9069 4.12 <0.0001 1.62 0.0993 3.63 <0.0001
HR max 0.21 0.6510 4.44 <0.0001 1.75 0.0699 3.70 <0.0001
Oxygen pulse 0.41 0.5325 1.61 0.0744 0.61 0.8459 3.57 <0.0001
VE max 0.09 0.7675 3.78 <0.0001 1.23 0.2807 3.15 0.0002
Total time 0.43 0.5241 9.61 <0.0001 4.12 <0.0001 6.57 <0.0001
Hematocrit 12.90 0.0021 6.51 <0.0001 1.56 0.1168 12.38 <0.0001
Hemoglobin 6.77 0.0180 8.48 <0.0001 1.25 0.2635 12.94 <0.0001
Iron 0.55 0.4670 3.30 0.0003 1.69 0.0811 2.91 0.0006
Ferritin 8.49 0.0093 3.48 <0.0001 1.12 0.3589 6.50 <0.0001
Transferrin 1.98 0.1769 2.97 0.0003 0.96 0.5055 3.11 0.0003
Transf sat 1.25 0.2785 2.98 0.0003 1.62 0.0976 3.10 0.0003
MCH 0.03 0.8603 6.36 <0.0001 1.82 0.0551 6.61 <0.0001
MCHC 0.01 0.9105 8.10 <0.0001 2.64 0.0045 6.81 <0.0001
MCV 0.03 0.8689 4.14 <0.0001 1.35 0.2047 4.26 <0.0001
MPV 2.77 0.1136 2.47 0.0028 1.11 0.3699 2.71 0.0013
RBC 6.93 0.0169 6.31 <0.0001 1.18 0.3122 11.67 <0.0001
RDW 1.05 0.3181 10.74 <0.0001 2.02 0.0303 10.70 <0.0001
WBC 0.89 0.3589 0.86 0.5990 0.46 0.9445 1.61 0.0821
Platelets 0.09 0.7639 3.37 <0.0001 1.43 0.1670 3.14 0.0002
Pmax maximal power output, VO2peak maximal aerobic consumption, Hb mass hemoglobin mass, EPO erythropoietin, HR heart rate, VE ventilation, Transf sat
transferrin saturation, MCH mean corpuscular hemoglobin, MCHC mean corpuscular hemoglobin concentration, MCV mean corpuscular volume, MPV mean platelet
volume, RBC red blood cell count, RDW red blood cell distribution width, WBC white blood cell count
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was found in the donation group (Table 2). Values before
beginning the third test series were higher than pre-
values in the first test series (Fig. 4b). Within the first
test series, erythropoietin concentration increased by
50% 2d, by 100% 1w, and by 75% 2w after donation. This
within test series augmentation was not observed in test
series 2 and 3.
Whole Blood Donation Affects Key Hematological
Parameters for Oxygen Transport: Additive Effect of
Repetitions
A global group effect was found for hematocrit,
hemoglobin concentration, ferritin, and RBC (Table 2). A
clear difference was observed between the placebo and the
donation group in the evolution of those four parameters,
all of which being important for oxygen transport. The
regulation of hematocrit, hemoglobin concentration, fer-
ritin, and RBC after each blood donation was similar to
the regulation of hemoglobin mass, i.e., no difference in
the placebo group and a decrease within each test series
in the donation group. The maximal decrease after a
blood donation observed in each parameter was 11% for
hematocrit, 10% for hemoglobin concentration, 50% for
ferritin, and 12% for RBC (Table 4). Contrary to
hemoglobin mass, which recovered basal values before be-
ginning the second and the third test series, values before
test series 2 and 3 for hematocrit, hemoglobin concentra-
tion, ferritin, and RBC were all lower compared to values
before test series 1 in the donation group (Table 4). Those
results indicate that repeated blood donations decreased
the levels of hematocrit, hemoglobin concentration, fer-
ritin, and RBC more than one single donation. Serum iron
levels (Table 4) and transferrin saturation (additional file
1) followed a similar pattern as the aforementioned pa-
rameters but the variation between subjects was higher,
leading to somewhat less numerous significant decreases.
Values for MCH and MCHC decreased and values for
RDW increased over time in each group (Table 2). The
amplitude of the decreases was small (max 4% for MCH
and MCHC and 5% for RDW) but very consistent within
each subject (Table 4). A general time effect was observed
for MCV, MPV, and platelets but only in the donation
group (Table 2 and additional file 1). WBC levels were not
modified by any condition (additional file 1).
Discussion
The key findings of the present study are that (1) maximal
power output, VO2peak, and hemoglobin mass decreased
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Meurrens et al. Sports Medicine - Open  (2016) 2:43 Page 6 of 12
Table 3 Effect of repeated blood donations on exercise parameters
Test series 1 Test series 2 Test series 3
-1w 2d 1w 2w 4w -1w 2d 1w 2w 4w -1w 2d 1w 2w 4w
Lactate 190W P 3.8 ± 1.1 3.2 ± 1.0 3.5 ± 1.1 3.5 ± 1.2 3.5 ± 1.2 2.1 ± 0.8# 3.1 ± 1.5 3.0 ± 1.4* 2.9 ± 1.2* 3.1 ± 1.4* 2.8 ± 1.1## 2.6 ± 1.0 2.2 ± 0.9 2.1 ± 0.7* 1.7 ± 0.3*
(mmol/l) D 2.8 ± 0.3 3.1 ± 0.3 3.0 ± 0.4 3.0 ± 0.3 2.6 ± 0.4 2.0 ± 0.2## 2.3 ± 0.3* 2.5 ± 0.3** 2.1 ± 0.3 2.1 ± 0.2 2.4 ± 0.4### 2.1 ± 0.3 2.0 ± 0.3* 1.8 ± 0.3** 1.7 ± 0.2***
Lactate post P 11.9 ± 0.8 12.1 ± 0.7 11.6 ± 0.2 13.6 ± 1.1 13.2 ± 1.9 9.3 ± 0.9 10.2 ± 2.3 10.7 ± 1.8 9.7 ± 0.9 11.2 ± 1.2 10.2 ± 1.3 9.8 ± 0.7 10.3 ± 1.3 9.8 ± 1.1 8.7 ± 1.0
(mmol/l) D 13.6 ± 0.8 13.0 ± 1.0 12.1 ± 1.1 11.8 ± 1.0 10.8 ± 0.6** 11.5 ± 1.1## 10.9 ± 0.9 11.0 ± 1.1 10.8 ± 0.9 10.6 ± 0.8 11.8 ± 1.0### 10.2 ± 1.3 9.5 ± 1.2* 10.1 ± 0.7 9.2 ± 0.9*
HR max P 184 ± 4 183 ± 3 179 ± 5* 178 ± 6* 177 ± 4** 169 ± 7# 174 ± 5* 174 ± 4* 178 ± 4** 175 ± 5* 176 ± 4 174 ± 5 177 ± 4 180 ± 5 177 ± 4
(bpm) D 187 ± 4 187 ± 3 183 ± 3* 180 ± 3*** 182 ± 3** 180 ± 4# 181 ± 3 182 ± 2 182 ± 2 180 ± 3 181 ± 3### 178 ± 3 175 ± 5 181 ± 3 179 ± 4
Oxygen pulse P 0.31 ± 0.02 0.31 ± 0.03 0.30 ± 0.03 0.31 ± 0.03 0.29 ± 0.03 0.32 ± 0.04 0.30 ± 0.03 0.31 ± 0.04 0.29 ± 0.03 0.28 ± 0.03 0.29 ± 0.03 0.30 ± 0.04 0.29 ± 0.03 0.29 ± 0.03 0.30 ± 0.04
(ml O2/beat/kg) D 0.31 ± 0.01 0.30 ± 0.02 0.29 ± 0.01* 0.29 ± 0.01** 0.29 ± 0.01* 0.30 ± 0.01## 0.28 ± 0.01* 0.29 ± 0.01 0.30 ± 0.01 0.30 ± 0.01 0.29 ± 0.01## 0.27 ± 0.01* 0.28 ± 0.01* 0.26 ± 0.01** 0.27 ± 0.01*
VE max P 139 ± 11 132 ± 14 130 ± 15 125 ± 15 124 ± 11* 131 ± 8 119 ± 10 133 ± 10 136 ± 12 137 ± 17 138 ± 16 134 ± 11 139 ± 12 147 ± 11* 139 ± 13
(l/min) D 135 ± 7 135 ± 6 130 ± 6 128 ± 9 126 ± 8 123 ± 7# 122 ± 7 131 ± 7* 137 ± 7** 126 ± 6 145 ± 7 131 ± 8* 134 ± 7* 143 ± 7 135 ± 6
Total time P 16.9 ± 1.2 16.7 ± 1.2 16.7 ± 1.4 16.7 ± 1.5 16.9 ± 1.4 17.4 ± 2.4# 18.3 ± 3.1* 18.2 ± 2.3* 18.3 ± 2.4* 18.4 ± 2.4* 18.0 ± 2.2### 18.1 ± 2.2 18.9 ± 2.4 19.5 ± 2.2* 18.3 ± 1.7
(min) D 16.9 ± 0.9 16.1 ± 1.0** 16.2 ± 0.8*** 16.3 ± 0.8*** 16.5 ± 0.9* 17.7 ± 1.1 17.2 ± 1.2* 16.9 ± 1.2 17.9 ± 1.2 17.8 ± 1.2 17.4 ± 1.1 16.8 ± 1.1 17.7 ± 1.1 18.5 ± 1.2 17.1 ± 0.9
Values are means ± SEM (n = 7 in P and n = 13 in D for test series 1; n = 5 in P and n = 13 in D for test series 2 and 3. HR heart rate, VE ventilation, P placebo, D donation. #p < 0.05, ##p < 0.01, ###p < 0.001 vs. -1w of test
series 1, same group. *p < 0.05, **p < 0.01, ***p < 0.001 vs. -1w of the same test series, same group
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up to 4 weeks after a single whole blood donation in mod-
erately trained people; (2) training adaptations seemed
somewhat lowered by repeated whole blood donations as
endurance capacity did not increase following multiple
maximal exercise tests in the donation while it did in the
placebo group; (3) key hematological parameters for oxy-
gen transport were lowered by a single whole donation
and cumulatively further affected by the repetition of the
donations; and (4) submaximal lactate levels, reflecting
submaximal endurance capacity, were not modified by
whole blood donation.
For the first time, a comprehensive study was per-
formed including repeated blood donations and assess-
ment of endurance capacity, hematological parameters,
and hemoglobin mass by the optimized CO rebreathing
method, with a follow-up of 4 weeks after each donation.
In addition, a placebo group was included, which
strongly increased the power of the study and thereby,
the interpretation of the results. Except one study [28],
all others failed to include such group and the compari-
sons were made before and after blood donation. When
looking at short-term adaptations of a few hours or days,
the lack of a placebo group is less critical and a pre-post
analysis can be considered as sufficient. When changes
are expected on the long term, the inclusion of a placebo
group is mandatory, as the time between two measure-
ments becomes a variable by itself. In the present case,
the placebo group allowed the distinction between the
effects caused by blood donation and the effects caused
by the repetition of the exercise tests, which was
expected to induce a global training effect. A typical
example is the improvement of the maximal power out-
put during test series 2 and 3 in the placebo group only.
Without a placebo group, we could have concluded that
a single donation alters maximal power output while re-
peated donations did not. The results of the placebo
group indicate that the normal response to 15 maximal
incremental tests is a global improvement in maximal
power output. The conclusion is therefore that repeated
blood donations reduce adaptations to training, at least
at the level of maximal power output. On the other
hand, the decrease in VO2peak in the donation group
during the first test series is not totally attributable to
blood donation as a decrease was observed after 1 and
4 weeks in the placebo group as well. It is therefore
likely that the decrease in VO2peak we observed during
the first test series was not totally attributable to dona-
tion itself but also to fatigue induced by repeated
Fig. 4 Hemoglobin mass and serum erythropoietin. Evolution of the hemoglobin mass (a) and serum erythropoietin (EPO, b) levels before and
after each of the three test series in the placebo and donation groups. Data are expressed as means ± SEM. n = 3 in placebo and n = 7 in
donation for test series 1, 2, and 3. ##p < 0.01 vs. -1w of test series 1, same group. *p < 0.05, **p < 0.01, ***p < 0.001 vs. -1w of the same test series,
same group
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Table 4 Effect of repeated blood donations on hematological parameters
Test series 1 Test series 2 Test series 3
-1w 2d 1w 2w 4w -1w 2d 1w 2w 4w -1w 2d 1w 2w 4w
Hematocrit P 46.6 ± 1.2 46.4 ± 0.6 46.1 ± 1.0 46.4 ± 1.3 46.1 ± 1.1 44.5 ± 1.5 45.3 ± 1.5 44.7 ± 1.4 46.2 ± 1.5 46.3 ± 1.5 43.5 ± 1.6 45.9 ± 1.2 46.0 ± 1.2 45.9 ± 0.9 45.3 ± 1.5
(%) D 45.8 ± 0.6 40.9 ± 0.9*** 41.9 ± 0.6*** 42.4 ± 0.5*** 43.9 ± 0.5** 44.5 ± 0.5### 42.2 ± 0.6*** 41.0 ± 0.5*** 43.0 ± 0.4** 43.2 ± 0.5** 43.8 ± 0.5### 41.7 ± 0.7*** 41.9 ± 0.6*** 42.1 ± 0.7*** 43.4 ± 0.5
Hemoglobin P 15.9 ± 0.6 15.7 ± 0.3 15.5 ± 0.5 15.4 ± 0.6 15.3 ± 0.5 15.0 ± 0.7 15.0 ± 0.7 14.9 ± 0.7 15.4 ± 0.7 15.3 ± 0.7 14.7 ± 0.8 15.2 ± 0.6 15.2 ± 0.6 15.2 ± 0.5 15.3 ± 0.8
(g/dl) D 15.6 ± 0.2 13.7 ± 0.3*** 14.2 ± 0.2*** 14.2 ± 0.2*** 14.5 ± 0.2*** 14.9 ± 0.2### 14.0 ± 0.3*** 13.7 ± 0.2*** 14.2 ± 0.2*** 14.4 ± 0.2** 14.6 ± 0.2### 13.7 ± 0.3*** 14.1 ± 0.2** 14.1 ± 0.3** 14.5 ± 0.2
Iron P 112 ± 20 101 ± 18 83 ± 17 98 ± 30 99 ± 20 85 ± 8 99 ± 35 78 ± 23 82 ± 11 110 ± 27 84 ± 19 136 ± 31 85 ± 13 133 ± 15 127 ± 36
(μg/dl) D 106 ± 9 90 ± 8 74 ± 8** 66 ± 7*** 96 ± 6 115 ± 20 101 ± 13 66 ± 7** 81 ± 10* 69 ± 6** 97 ± 9# 109 ± 9 76 ± 10 82 ± 11 99 ± 12
Ferritin P 72 ± 12 64 ± 14 56 ± 11 53 ± 11 58 ± 11 64 ± 16 50 ± 11 68 ± 18 64 ± 16 59 ± 11 77 ± 22 71 ± 17 82 ± 15 76 ± 15 69 ± 13
(μg/l) D 55 ± 8 45 ± 7* 43 ± 8* 37 ± 8*** 27 ± 5*** 40 ± 6## 42 ± 7 27 ± 4** 28 ± 3* 23 ± 4** 41 ± 5### 37 ± 5 30 ± 5*** 29 ± 4*** 33 ± 5**
MCH P 29.9 ± 0.6 29.7 ± 0.6 29.4 ± 0.6*** 29.4 ± 0.7** 29.4 ± 0.6** 29.9 ± 0.5### 29.4 ± 0.5 29.8 ± 0.5 29.9 ± 0.5 29.5 ± 0.6 29.8 ± 0.7## 29.6 ± 0.6 29.5 ± 0.5 29.6 ± 0.5 30.0 ± 0.6
(pg) D 30.0 ± 0.3 29.6 ± 0.4** 29.7 ± 0.4** 29.4 ± 0.3*** 29.5 ± 0.4*** 29.4 ± 0.4### 29.3 ± 0.4 29.4 ± 0.4 29.3 ± 0.4 29.1 ± 0.4 29.0 ± 0.4## 28.6 ± 0.4** 29.3 ± 0.4* 29.0 ± 0.5 29.1 ± 0.4
MCHC P 34.1 ± 0.4 33.7 ± 0.4* 33.6 ± 0.5*** 33.2 ± 0.5** 33.1 ± 0.4** 33.6 ± 0.5## 33.1 ± 0.6* 33.3 ± 0.6 33.3 ± 0.5 33.0 ± 0.6* 33.8 ± 0.8### 33.1 ± 0.7 33.0 ± 0.6 33.2 ± 0.6 33.6 ± 0.7
(g/dl) D 34.0 ± 0.2 33.6 ± 0.2** 33.8 ± 0.2* 33.4 ± 0.2*** 33.1 ± 0.3*** 33.6 ± 0.3### 33.2 ± 0.3 33.4 ± 0.2 33.1 ± 0.2* 33.3 ± 0.3 33.4 ± 0.3## 32.7 ± 0.3*** 33.6 ± 0.2 33.3 ± 0.3 33.4 ± 0.3
RDW P 12.9 ± 0.2 12.9 ± 0.2 13.0 ± 0.2 13.2 ± 0.2 13.2 ± 0.2* 13.1 ± 0.3# 13.2 ± 0.4 13.1 ± 0.4 13.2 ± 0.4 13.1 ± 0.3 13.2 ± 0.5## 13.4 ± 0.5 13.4 ± 0.5 13.4 ± 0.5 13.4 ± 0.6
(%) D 12.8 ± 0.1 12.7 ± 0.1 12.8 ± 0.1 12.9 ± 0.1 13.0 ± 0.1* 12.6 ± 0.1 12.7 ± 0.1** 13.0 ± 0.1*** 12.9 ± 0.1 12.8 ± 0.1 13.2 ± 0.1### 13.4 ± 0.2 13.3 ± 0.1 13.4 ± 0.1 13.1 ± 0.1
RBC P 5.3 ± 0.2 5.3 ± 0.1 5.3 ± 0.2 5.3 ± 0.2 5.2 ± 0.2 5.0 ± 0.2 5.1 ± 0.2 5.0 ± 0.2 5.1 ± 0.2 5.2 ± 0.1 5.0 ± 0.2 5.2 ± 0.1 5.2 ± 0.1 5.1 ± 0.1 5.1 ± 0.2
(1012/l) D 5.2 ± 0.1 4.6 ± 0.1*** 4.8 ± 0.1*** 4.8 ± 0.1*** 4.9 ± 0.1** 5.1 ± 0.1### 4.8 ± 0.1*** 4.7 ± 0.1*** 4.9 ± 0.1** 4.9 ± 0.1* 5.1 ± 0.1### 4.8 ± 0.1*** 4.8 ± 0.1*** 4.8 ± 0.1*** 5.0 ± 0.1
Values are means ± SEM (n = 7 in P and n = 13 in D for test series 1; n = 5 in P and n = 13 in D for test series 2 and 3. MCH mean corpuscular hemoglobin, MCHC mean corpuscular hemoglobin concentration, RDW red
blood cell distribution width, RBC red blood cell count, P placebo, D donation. #p < 0.05, ##p < 0.01, ###p < 0.001 vs. -1w of test series 1, same group. *p < 0.05, **p < 0.01, ***p < 0.001 vs. -1w of the same test series,
same group
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exercise tests. Interestingly, not only endurance parame-
ters were affected by the repetition of the exercise tests,
MCH, MCHC, and RDW were also training-sensitive,
independently of the group. All together those results
highlight the importance of including a placebo group
when studies are performed on the long term.
We found a reduced maximal power output and
VO2peak of a few percent up to 4 weeks after the first
blood donation. The largest reduction in maximal power
output was 4% and in VO2peak 11%, which corresponds
to values previously reported [15, 20, 22, 24]. Only one
study extended the recovery period until 4 weeks [15].
The main results of that study were that running per-
formance on a 3-km time test series and VO2peak were
reduced up to 1 week and hemoglobin concentration up
to 2 weeks. In another study, VO2peak was shown to be
reduced up to 2 weeks after donation while time to fa-
tigue was not affected [24]. Here, we used a similar exer-
cise protocol, i.e., maximal incremental test on a cycle
ergometer, to determine endurance capacity and
VO2peak. It is therefore surprising that endurance cap-
acity was differently affected after blood donation. It is
possible that the training status influences the effect of
donation on endurance capacity as our subjects had an
averaged VO2peak of 57 mlO2/kg/min and in Judd et al.
a VO2peak of 47 mlO2/kg/min. One could postulate that
somewhat better endurance-trained athletes will have a
different reaction to blood donation than less well
trained and could develop iron deficiency more rapidly
as they usually have a low iron status. To confirm this
hypothesis, subjects with different endurance training
levels should be tested in the same study design but elite
athletes are not willing to undergo blood donation,
knowing the negative impact on their performance, even
if temporary. The reduction in performance and VO2peak
after blood donation is probably due to the limitation of
blood oxygen transport capacity. Hematocrit, hemoglobin
concentration, hemoglobin mass, ferritin, iron, and RBC
were all reduced after blood donation and their values
were still lower than basal values after 4 weeks, except for
iron and hemoglobin mass. We hereby confirm previous
reports showing that recovery of hematological parame-
ters may take a few weeks or even more [15–17]. Here,
hematocrit, hemoglobin concentration, ferritin, and RBC
were still lower 3 months after the first blood donation, at
the time of beginning the second test series, indicating
that the recovery of those parameters was incomplete be-
fore the next blood donation. It is therefore not surprising
to observe an additive effect of repeating blood donation
on those parameters.
To the best of our knowledge, no study has prospect-
ively analyzed the impact of repeated blood donations
on endurance capacity. We found that maximal power
output was mainly affected after the first donation with
a minor impact after the second and the third one.
Nevertheless, the expected improvement in maximal
power output after repeated exercise tests, as observed
in the placebo group, was not present in the donation
group. It seems therefore that training adaptations are
impaired due to repeated donations, probably due to a
decrease in key hematological parameters. Hematocrit,
hemoglobin concentration, ferritin, and RBC all de-
creased globally over time, not only within one test
series. We hereby extend the results of a previous study
looking at the effect of repeated blood donations on
serum ferritin concentrations [17]. Ferritin levels were
directly inversely proportional to the number of dona-
tions per year, with the lowest concentrations measured
in people who gave blood thrice a year [17]. Of note, our
subjects did not receive any iron supplementation as
they had a normal iron status at baseline and were not
considered at risk for anemia. Our results show that
even in a population a priori without risk for iron defi-
ciency, it would be interesting to consider an orientation
of the diet towards an iron-rich diet and/or iron supple-
mentation to try to limit the negative effect of repeated
blood donations on iron status. At the same time, this
could limit the reduction in endurance performance.
Further investigation should therefore focus on possible
countermeasures to limit the side effects of repeated
blood donation on iron status and endurance perform-
ance. Of note, our subjects were not sensu stricto iron
deficient as their ferritin levels were above 15 μg/l
(World Health Organization) but it should be acknowl-
edged that endurance performance can be altered before
iron deficiency really takes place.
Measurement of hemoglobin and ferritin concentra-
tion as well as hematocrit to assess hematological recov-
ery after blood donation may not reflect the true
amount of blood as both are affected by changes in
plasma volume. Instead, total hemoglobin mass has been
proposed to be the most sensitive variable to assess
hematological recovery [16]. After one blood donation,
total hemoglobin mass has been shown to be reduced by
about 8–9% and to recover pre-donation values after
35 days in average [16]. Of note, this recovery period
was highly variable, ranging from 20 to 59 days. Here,
we found similar amplitude in the decrease in total
hemoglobin mass, which was recovered after 4 weeks in
test series 1 and 2 but took more than 4 weeks in test
series 3, indicating that the recovery period was longer
when the donations were repeated. Concomitantly,
serum erythropoietin levels were higher during the third
donation, slightly increasing over time from the first
measurement to the end of the study in the donation
group. Erythropoietin is a critical hormone in the forma-
tion of red blood cells in the bone marrow, thereby in-
creasing total hemoglobin mass [29]. Taken together, the
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evolution of hemoglobin mass and erythropoietin sug-
gests that the regenerating capacity of total hemoglobin
mass was slower with the repetition of blood donations.
Interestingly, the decrease in hemoglobin mass was pre-
ceded by a decrease in hematocrit, hemoglobin concen-
tration, RBC, and ferritin. As the quantification of the
latter parameters is performed in routine when donating
blood, a continuous decrease in their level could be
interpreted as a premature sign of a later decrease in
hemoglobin mass, which is more complex to assess. As
hematological parameters are key factors in the adapta-
tion to endurance exercise [14, 30], it is not surprising to
see no improvement of maximal power output in the do-
nation group while this was the case in the placebo group
with the repetition of the maximal efforts. Notably, blood
lactate concentrations at 190 W, which reflect submaxi-
mal training adaptations, decreased similarly over time in
both groups. We hereby confirm a previous report show-
ing that submaximal endurance capacity is not altered by
blood donation [21].
The interpretation of the present results is limited to
the population we studied, i.e., moderately trained
people. As mentioned above, one can speculate that ath-
letes with higher hemoglobin mass and VO2peak [31]
would suffer greater losses in performance from blood
donation. In addition, at the beginning of the study, half
of the subjects were regular donors (three times a year)
while the other half were not (one time or less a year).
As already shown retrospectively in male Saudi blood
donors, the higher the frequency of blood donations, the
lower the ferritin concentrations [32], and probably the
higher risk of developing iron deficiency. Here as well,
regular donors had lower ferritin concentrations at the
beginning of the study than non-regular donors (data
not shown). However, no difference was observed be-
tween those two groups in the drop of Pmax or
VO2peak after the first donation, indicating that the
antecedent of the donors had a limited impact on our
main outcome, endurance capacity. Another limitation
of the present study is that we did not determine the an-
aerobic threshold and as a consequence no distinction
could be made between the aerobic and anaerobic mus-
cular work. Whether blood donation induces a shift in
the anaerobic threshold due to reduced capacity for car-
rying oxygen remains to be tested.
Practically, the changes we observed in maximal power
output and VO2peak were rather limited for a moder-
ately trained population. Endurance capacity was re-
duced by a few percent for 4 weeks, which should not
prevent moderately trained athletes to give blood as
other uncontrolled factors such as the form of the day, a
poor hydration status, motivation, work-induced fatigue,
or familial emergency would have an impact of the same
magnitude on their performance. We can recommend to
those athletes not to plan an important race the month
following a blood donation or not to donate blood the
month before an important race. For elite athletes, blood
donation is not to be recommended for the direct effect
on endurance performance but also for the impairment
repeated donations have on training adaptations. Redu-
cing performance by a few percent can have dramatic
consequences on the ranking. But this concerns only a
small proportion of the total number of people prac-
ticing physical activity and participating in sport events.
Conclusions
The present study is the first to look at the effect of re-
peated whole blood donation on endurance capacity and
key hematological parameters for oxygen transport,
among which is hemoglobin mass. We found that max-
imal, but not submaximal, endurance capacity was al-
tered after blood donation in moderately trained people
and that the expected training effects were lower when
repeating blood donations. Those alterations are prob-
ably partially due to reductions in the iron status, red
blood cells, and hemoglobin mass. Measures to counter-
act the alterations in hematological parameters should
be developed to minimize alterations in endurance cap-
acity and thereby to attract more athletes to become do-
nors. Finally, athletes constitute a very healthy potential
donor population and should consider becoming plasma
donors as there also is an increased need for plasma
worldwide and plasma donation does not affect their
hemoglobin levels at all.
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